INCIDENCE OF MAJOR ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JAK-INHIBITORS COMPARED TO BDMARDS: DATA FROM AN INTERNATIONAL COLLABORATION OF REGISTRIES (THE "JAK-POT" STUDY)

被引：2
|
作者：
Aymon, R. [1 ]
Mongin, D. [1 ]
Bergstra, S. A. [2 ]
Choquette, D.
Codreanu, C. [3 ,4 ]
Cordtz, R. L. [5 ]
Diederik, D. C. [6 ]
Dreyer, L. [5 ]
Elkayam, O. [7 ]
Huschek, D. [8 ]
Hyrich, K. [9 ]
Iannone, F. [10 ]
Inanc, N. [11 ]
Kearsley-Fleet, L.
Kvien, T. K. [12 ]
Leeb, B. [13 ]
Lukina, G. [14 ]
Nordstrom, D. [15 ]
Onen, F. [16 ]
Pavelka, K. [17 ]
Pombo-Suarez, M. [18 ]
Provan, S. Aarrestad
Rodrigues, A. M. [19 ]
Rotar, Z. [20 ,21 ]
Strangfeld, A. [8 ]
Verschueren, P.
Zavada, J.
Courvoisier, D. [1 ]
Finckh, A. [1 ]
Lauper, K. [1 ]
机构：
[1] Geneva Univ Hosp, Div Rheumatol, Geneva, Switzerland
[2] LUMC, Rheumatol, Leiden, Netherlands
[3] CHUM, Inst Rech Rhumatol, Montreal, PQ, Canada
[4] Univ Med, Ctr Rheumat Dis, Bucharest, Romania
[5] Aalborg Univ Hosp, Rheumatol, DANBIO, Aalborg, Denmark
[6] Vrije Univ Brussels, Dept Publ Hlth, Biostat & Med Informat Res Grp, Brussels, Belgium
[7] Tel Aviv Univ, Rheumatol, Tel Aviv, Israel
[8] DRFZ, Programme Area Epidemiol, Berlin, Germany
[9] Univ Manchester, Ctr Epidemiol Versus Arthrit, Manchester, Lancs, England
[10] Univ Hosp Bari, GISEA, Rheumatol, Bari, Italy
[11] Marmara Univ, Sch Med, Rheumatol, Istanbul, Turkiye
[12] Diakonhjemmet Hosp, Ctr Treatment Rheumat & Musculoskeletal Dis REMED, Oslo, Norway
[13] BioReg, Vienna, Austria
[14] AS Loginov Moscow Clin Sci Ctr, VA Nasonova Res Inst, Rheumatol, Moscow, Russia
[15] Helsinki Univ Hosp, ROB FIN, Helsinki, Finland
[16] Dokuz Eylul Univ, Fac Med, Dept Internal Med, Div Rheumatol, Izmir, Turkiye
[17] Inst Rheumatol, Rheumatol, Prague, Czech Republic
[18] Hosp Clin Univ, Rheumatol, Santiago De Compostela, Spain
[19] Univ Nova Lisboa, Inst Med Mol, NOVA Med Sch,CHRC, Rheumatol Res Unit,Rheuma Pt,Soc Portuguesa Rheum, Lisbon, Portugal
[20] Univ Med Ctr Ljubljana, Ljubljana, Slovenia
[21] Univ Ljubljana, Rheumatol, Ljubljana, Slovenia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Disease-modifying drugs (DMARDs); Safety; Real-world evidence;
D O I：
10.1136/annrheumdis-2023-eular.660
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0219
引用
收藏
页码：143 / 145
页数：3
相关论文
共 34 条
  • [1] Incidence of major adverse cardiovascular events in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: data from an international collaboration of registries (the "JAK-pot" study)
    Aymon, R.
    Mongin, D.
    Bergstra, S. A.
    Choquette, D.
    Codreanu, C.
    Cordtz, R. L.
    De Cock, D.
    Dreyer, L.
    Elkayam, O.
    Huschek, D.
    Hyrich, K. L.
    Iannone, F.
    Inanc, N.
    Kearsley-Fleet, L.
    Kvien, T. K.
    Leeb, B. F.
    Lukina, G.
    Nordstrom, D.
    Onen, F.
    Pavelka, K.
    Pombo-Suarez, M.
    Provan, S.
    Rodrigues, A. M.
    Rotar, Z.
    Strangfeld, A.
    Verschueren, P.
    Zavada, J.
    Courvoisier, D.
    Finckh, A.
    Lauper, K.
    SWISS MEDICAL WEEKLY, 2023, 153 : 2S - 2S
  • [2] Infections in patients with rheumatoid arthritis treated with JAK-inhibitors compared to bDMARDs: findings from an international collaboration of registers (the "JAK-pot" study)
    Aymon, R.
    Mongin, D.
    Gilbert, B.
    Guemara, R.
    Choquette, D.
    Codreanu, C.
    Flouri, I
    Huchek, D.
    Hyrich, K.
    Iannone, F.
    Kearsley-Fleet, L.
    Kvien, T. K.
    Leeb, B. F.
    Nordstrom, D.
    Pavelka, K.
    Pombo-Suerez, M.
    Provan, S. A.
    Rodrigues, A. M.
    Ziga, Rotar
    Sidiropoulos, P.
    Strangfeld, A.
    Trokovic, N.
    Zavada, J.
    Courvoisier, D.
    Finckh, A.
    Lauper, K.
    SWISS MEDICAL WEEKLY, 2024, 154 : 21S - 21S
  • [3] Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot' study)
    Aymon, Romain
    Mongin, Denis
    Bergstra, Sytske Anne
    Choquette, Denis
    Codreanu, Catalin
    De Cock, Diederik
    Dreyer, Lene
    Elkayam, Ori
    Huschek, Doreen
    Hyrich, Kimme L.
    Iannone, Florenzo
    Inanc, Nevsun
    Kearsley-Fleet, Lianne
    Koca, Suleyman Serdar
    Kvien, Tore K.
    Leeb, Burkhard F.
    Lukina, Galina
    Nordstrom, Dan C.
    Pavelka, Karel
    Pombo-Suarez, Manuel
    Rodrigues, Ana
    Rotar, Ziga
    Strangfeld, Anja
    Verschueren, Patrick
    Westermann, Rasmus
    Zavada, Jakub
    Courvoisier, Delphine Sophie
    Finckh, Axel
    Lauper, Kim
    ANNALS OF THE RHEUMATIC DISEASES, 2024, 83 (04) : 421 - 428
  • [4] Insights on the Use of JAK-inhibitors in Patients with Psoriatic Arthritis in an International Collaboration of Registers (the "JAK-pot" Study)
    Aymon, Romain
    Mongin, Denis
    Leeb, Burkhard
    Mustak-Blagusz, Monika
    Zavada, Jakub
    Pavelka, Karel
    Nordstrom, Dan
    Trokovic, Nina
    Iannone, Florenzo
    Codreanu, Catalin
    Rotar, Ziga
    Kvien, Tore
    Provan, Sella
    Suarez, Manuel Enrique Pombo
    Alonso, Fernando
    Onen, Fatos
    Inanc, Nevsun
    Coupal, Louis
    Choquette, Denis
    Lukina, Galina
    Elkayam, Ori
    Furer, Victoria
    Rodrigues, Ana Maria
    Courvoisier, Delphine
    Finckh, Axel
    Nissen, Michael
    Lauper, Kim
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3366 - 3368
  • [5] Heterogeneity in the Pattern of Use of JAK-inhibitors Between Countries Participating in an International Collaboration of Registers of Rheumatoid Arthritis Patients (the JAK-pot Study)
    Lauper, Kim
    Mongin, Denis
    Bergstra, Sytske Anne
    Choquette, Denis
    Codreanu, Catalin
    Elkayam, Ori
    Hyrich, Kimme
    Iannone, Florenzo
    Kristianslund, Eirik
    Kvien, Tore
    Leeb, Burkhard
    Lukina, Galina
    Nordstrom, Dan
    Onen, Fatos
    Pavelka, Karel
    Pombo-Suarez, Manuel
    Rotar, Ziga
    Santos, Maria Jose
    Strangfeld, Anja
    Courvoisier, Delphine
    Finckh, Axel
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [6] Comparative effectiveness of JAK-inhibitors, TNF-inhibitors, abatacept and IL-6 inhibitors in an international collaboration of registers of rheumatoid arthritis patients (the "JAK-pot" study)
    Lauper, K.
    Mongin, D.
    Bergstra, S. A.
    Choquette, D.
    Catalin, Codreanu
    De Cock, D.
    Lene, Dreyer
    Elkayam, O.
    Hyrich, K.
    Iannone, F.
    Inanc, N.
    Kristianslund, E.
    Kvien, T. K.
    Leeb, B.
    Lukina, G.
    Nordstrom, D.
    Pavelka, K.
    Pombo Suarez, M.
    Rotar, Z.
    Santos, M. J.
    Strangfeld, A.
    Courvoiser, D. S.
    Finckh, A.
    SWISS MEDICAL WEEKLY, 2020, : 8S - 8S
  • [7] COMPARATIVE EFFECTIVENESS OF JAK-INHIBITORS, TNF-INHIBITORS, ABATACEPT AND IL-6 INHIBITORS IN AN INTERNATIONAL COLLABORATION OF REGISTERS OF RHEUMATOID ARTHRITIS PATIENTS (THE "JAK-POT" STUDY)
    Lauper, K.
    Mongin, D.
    Bergstra, S. A.
    Choquette, D.
    Codreanu, C.
    De Cock, D.
    Dreyer, L.
    Elkayam, O.
    Hyrich, K.
    Iannone, F.
    Inanc, N.
    Kristianslund, E.
    Kvien, T. K.
    Leeb, B.
    Lukina, G.
    Nordstrom, D.
    Pavelka, K.
    Pombo-Suarez, M.
    Rotar, Z.
    Santos, M. J.
    Strangfeld, A.
    Courvoisier, D.
    Finckh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 146 - 147
  • [8] Evaluation of Treatment Discontinuation Due to Adverse Events, and the Effect of Cardiovascular Risk Factors or Type of JAK-inhibitors: An International Collaboration of Registries of Rheumatoid Arthritis Patients (the
    Lauper, Kim
    Aymon, Romain
    Mongin, Denis
    Bergstra, Sytske Anne
    Choquette, Denis
    Codreanu, Catalin
    Elkayam, Ori
    Hyrich, Kimme
    Iannone, Florenzo
    Inanc, Nevsun
    Kearsley-Fleet, Lianne
    Kvien, Tore K.
    Kristianslund, Eirik
    Leeb, Burkhard
    Lukina, Galina
    Nordstrom, Dan
    Pavelka, Karel
    Pombo-Suarez, Manuel
    Rotar, Ziga
    Santos, Maria Jose
    Courvoisier, Delphine
    Finckh, Axel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 558 - 561
  • [9] How Fast Do JAK-inhibitors, TNF- inhibitors, Abatacept and IL-6 Inhibitors Act in Rheumatoid Arthritis? An International Collaboration of Registers of Rheumatoid Arthritis Patients (the "JAK-pot" Study)
    Courvoisier, Delphine Sophie
    Mrad, Yacine
    Mongin, Denis
    Aymon, Romain
    Caporali, Roberto
    Choquette, Denis
    Codreanu, Catalin
    Coupal, Louis
    Huschek, Doreen
    Hyrich, Kimme
    Iannone, Florenzo
    Kvien, Tore K.
    Mustak, Monika
    Nordstrom, Dan
    Trokovic, Nina
    Otero-Varela, Lucia
    Pavelka, Karel
    Suarez, Manuel Enrique Pombo
    Provan, Sella A.
    Rodrigues, Ana Maria
    Rotar, Ziga
    Sidiropoulos, Prodromos
    Strangfeld, Anja
    Zavada, Jakub
    Zhao, Sizheng
    Finckh, Axel
    Lauper, Kim
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1014 - 1017
  • [10] HETEROGENEITY IN ADVERSE EVENT ASSESSMENT BETWEEN COUNTRIES PARTICIPATING IN AN INTERNATIONAL COLLABORATION OF REGISTRIES OF RHEUMATOID ARTHRITIS PATIENTS USING JANUS KINASE INHIBITORS (THE JAK-POT STUDY)
    Lauper, K.
    Mongin, D.
    Bergstra, S. A.
    Choquette, D.
    Codreanu, C.
    De Cock, D.
    Dreyer, L.
    Elkayam, O.
    Hyrich, K.
    Iannone, F.
    Inanc, N.
    Kristianslund, E.
    Kvien, T. K.
    Leeb, B.
    Lukina, G.
    Nordstrom, D.
    Pavelka, K.
    Pombo-Suarez, M.
    Rotar, Z.
    Santos, M. J.
    Strangfeld, A.
    Courvoisier, D.
    Finckh, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 256 - 257
1234